Quarter Period Consolidated Statement Of Comprehensive Income

OncoTherapy Science, Inc. - Filing #7253509

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-815,202,000 JPY
-815,202,000 JPY
-815,202,000 JPY
-815,285,000 JPY
-815,202,000 JPY
-1,007,782,000 JPY
-1,288,138,000 JPY
-1,007,782,000 JPY
-1,007,782,000 JPY
-1,007,782,000 JPY
Comprehensive income
-815,285,000 JPY
-1,288,138,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-815,285,000 JPY
-1,288,138,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.